HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 458 participants.
Also called NCT07379190
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 458 participants
- Registry
-
NCT07379190
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07379190. Randomized; single masking; primary purpose treatment. Start 2026-06-22 (actual); primary completion 2029-02-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)
- Condition
- Stroke, Acute
- Condition
- Stroke, Ischemic
- Condition
- Cerebral Infarction
- Intervention (Drug)
- Tirofiban
- Intervention (Drug)
- dual antiplatelet therapy
- Lead sponsor
- Weifang Medical University
- Collaborator
- Linyi People's Hospital
- Collaborator
- Qianfoshan Hospital
Record details
- Record id
cardio:ct-nct07379190- Content hash
dc181cda97eaab9b0614877570d938c5b738719f4d98cf37d535b14cb07b9df0